Australia, Oct. 8 -- AstraZeneca AB, owns the trademark (2569845) for 'EXKALBRI' till June 5, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations and substances for the treatment of cardiovascular, metabolic, and renal diseases and disorders.]
Type of Mark: Word
Date of Acceptance: July 29
Registration Advertised: Oct. 7
For further details contact DENNEMEYER & ASSOCIATES.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2569845.
Disclaimer: Curated by HT Syndication.
